Minor
IMPACT-MS · Treatment · Primary or Secondary Progressive Multiple Sclerosis
Trial sites expanded: 2 → 8 locations
Tr1X, Inc.Phase 1/2 NCT07477639 Registry history of NCT07477639 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 2 → 8 locations
Tr1X, Inc.Phase 1/2 NCT07477639 Registry history of NCT07477639 on ClinicalTrials.gov (opens the registry)
| Phase 1 | 1 | |
| Phase 1/2 | 2 |
Acute Lymphoblastic Leukemia (ALL) (1) · Acute Myeloid Leukemia (AML) (1) · Crohn's Disease (1) · Leukemia (1) · MDS/MPN Overlap (1) · Multiple Sclerosis (1) · Myelodysplastic Syndromes (MDS) (1)